What were the main drivers of the revenue growth in the third quarter of 2012?

Revenue growth was primarily driven by the continued adoption of the TASER X2 Electronic Control Device (ECD) and an increase in single cartridge sales. The Video segment, including AXON and EVIDENCE.com, also contributed significantly with sales nearly doubling year-over-year.

How has the company's profitability changed compared to the prior year?

Profitability has significantly improved. Gross margin expanded from 53.7% to 58.4% due to manufacturing efficiencies and a more favorable product mix. Net income increased by 223.7% to $3.7 million ($0.07 EPS) in Q3 2012.

What is the company's financial health and liquidity position?

The company's financial health appears strong. They reported $29.1 million in cash, cash equivalents, and investments as of September 30, 2012, and generated $23.3 million in net cash from operating activities for the first nine months of the year. They also have a $10.0 million revolving line of credit available.

What are the significant risks or contingencies the company is facing?

The company is involved in numerous product liability lawsuits related to the use of its TASER devices. While many cases have been dismissed or ruled in favor of the company, there is an ongoing appeal in the Turner case resulting in a $5.5 million judgment. Other risks include potential fluctuations in foreign currency exchange rates and competition.

AXON 10-Q Quarterly Report Q3 FY2012 — Revenue, Net Income, EPS

Summary

Axon Enterprise, Inc. (formerly TASER International, Inc.) reported a strong third quarter in 2012, demonstrating significant year-over-year growth in both revenue and net income. Net sales increased by 18.0% to $28.8 million, driven by robust demand for their TASER X2 Electronic Control Device (ECD) and increased cartridge sales. The company also saw substantial growth in its emerging Video segment, with sales nearly doubling. Profitability improved considerably, with gross margin expanding to 58.4% from 53.7% in the prior year's quarter, attributable to manufacturing efficiencies and a favorable product mix. Net income surged by 223.7% to $3.7 million, or $0.07 per share. The company's balance sheet remains healthy, with a solid cash position and positive operating cash flow of $23.3 million for the first nine months of the year. However, investors should note the ongoing litigation expenses and the company's stock repurchase program, which utilized $20 million in cash during the period.

Financial Highlights

46 data points

Beta

Revenue

$28.77M

0.6% Gross Margin

Net Income

$3.68M

0.1% Net Margin

EPS (Diluted)

$0.07

Total Assets

$102.59M

Cash & Equivalents

$25.97M

Free Cash Flow

$9.59M

Financial Statements

Beta

Revenue	$28.77M
Cost of Revenue	$11.97M
Gross Profit	$16.80M
R&D Expenses	$1.99M
SG&A Expenses	$9.54M
Operating Income	$5.28M
Net Income	$3.68M
EPS (Basic)	$0.07
EPS (Diluted)	$0.07
Shares Outstanding (Basic)	52.51M
Shares Outstanding (Diluted)	53.11M

Key Highlights

1Net sales increased by 18.0% to $28.8 million in Q3 2012 compared to Q3 2011.
2Net income saw a substantial increase of 223.7% to $3.7 million ($0.07 EPS) in Q3 2012 compared to $1.1 million ($0.02 EPS) in Q3 2011.
3Gross margin improved to 58.4% in Q3 2012 from 53.7% in Q3 2011, driven by manufacturing efficiencies and product mix.
4The TASER X2 ECD and single cartridges were key sales drivers, along with growth in the Video segment (AXON/EVIDENCE.com).
5Operating cash flow for the first nine months of 2012 was strong at $23.3 million.
6The company repurchased $20.0 million of its common stock during the first nine months of 2012.
7Ongoing litigation remains a factor, with specific mention of the Turner case resulting in a $5.5 million judgment against the company, partially covered by insurance.

AXON ENTERPRISE, INC. Quarterly Report for Q3 Ended Sep 30, 2012

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions